We are live on ! Find out more
BCM

Brooktree Capital Management Portfolio holdings

AUM $126M
1-Year Est. Return 0.5%
This Fund
S&P 500
This Quarter Est. Return
-15.05%
1 Year Est. Return
-0.5%
3 Year Est. Return
+57.3%
5 Year Est. Return
+44.35%
10 Year Est. Return
AUM
$133M
AUM Growth
-$20.3M
Cap. Flow
+$5.85M
Cap. Flow %
4.4%
Top 10 Hldgs %
66.31%
Holding
39
New
1
Increased
15
Reduced
17
Closed
5

Top Buys

Rank Stock Value
1
APPS icon
Digital Turbine
APPS
+$6.02M
2
PPLI
People Inc
PPLI
+$3.09M
3
QCOM icon
Qualcomm
QCOM
+$1.55M
4
FISV
Fiserv Inc
FISV
+$1.2M
5
CDLX icon
Cardlytics
CDLX
+$515K

Sector Composition

Rank Sector Weight
1 Technology 52.42%
2 Financials 18.69%
3 Healthcare 14.32%
4 Communication Services 7.38%
5 Industrials 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAR icon
1
PAR Technology
PAR
$716M
$15.1M 11.38%
404,023
+4,812
+1% +$173K
RMNI icon
2
Rimini Street
RMNI
$457M
$11.4M 8.54%
1,891,746
+19,089
+1% +$114K
IBKR icon
3
Interactive Brokers
IBKR
$38.4B
$10.2M 7.67%
742,184
+16,096
+2% +$239K
AAPL icon
4
Apple
AAPL
$4.97T
$8.39M 6.31%
61,399
-2,761
-4% -$418K
PPLI
5
People Inc
PPLI
$3.12B
$7.91M 5.94%
126,960
+43,873
+53% +$3.09M
BRK.B icon
6
Berkshire Hathaway Class B
BRK.B
$1.1T
$7.75M 5.82%
28,388
-139
-0.5% -$43.6K
THRY icon
7
Thryv Holdings
THRY
$184M
$7.69M 5.77%
343,291
+13,949
+4% +$358K
DXC icon
8
DXC Technology
DXC
$1.91B
$7.44M 5.59%
245,561
+6,000
+3% +$186K
PFE icon
9
Pfizer
PFE
$143B
$6.51M 4.89%
124,166
+2,621
+2% +$134K
JNJ icon
10
Johnson & Johnson
JNJ
$640B
$5.84M 4.39%
32,894
-491
-1% -$87.5K
APPS icon
11
Digital Turbine
APPS
$982M
$5.81M 4.36%
332,413
+222,112
+201% +$6.02M
MSFT icon
12
Microsoft
MSFT
$2.9T
$4.51M 3.39%
17,561
-670
-4% -$182K
FISV
13
Fiserv Inc
FISV
$29.7B
$4.46M 3.35%
50,167
+12,358
+33% +$1.2M
GD icon
14
General Dynamics
GD
$103B
$4.21M 3.16%
19,010
-280
-1% -$64.4K
BFH icon
15
Bread Financial
BFH
$4.32B
$3.67M 2.76%
98,986
+5,978
+6% +$305K
LLY icon
16
Eli Lilly
LLY
$1.08T
$3.03M 2.28%
9,341
-219
-2% -$65.7K
AMZN icon
17
Amazon
AMZN
$2.44T
$2.45M 1.84%
23,060
-1,180
-5% -$148K
ABBV icon
18
AbbVie
ABBV
$465B
$1.49M 1.12%
9,756
-1,816
-16% -$277K
QCOM icon
19
Qualcomm
QCOM
$164B
$1.46M 1.1%
+11,430
New +$1.55M
SCWX
20
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
$1.31M 0.98%
120,377
+34,601
+40% +$393K
JPM icon
21
JPMorgan Chase
JPM
$916B
$1.28M 0.96%
11,357
AVLR
22
DELISTED
Avalara, Inc.
AVLR
$1.22M 0.92%
17,333
+5,038
+41% +$414K
NEXN
23
Nexxen International
NEXN
$588M
$1.15M 0.86%
132,238
+20,464
+18% +$234K
WST icon
24
West Pharmaceutical
WST
$23.7B
$1.14M 0.85%
3,760
+615
+20% +$200K
ABT icon
25
Abbott
ABT
$187B
$1.05M 0.79%
9,667
-919
-9% -$104K

Similar funds

Brooktree Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Brooktree Capital Management held 39 positions worth $133M, down 13% from $153M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Brooktree Capital Management deployed $5.85M of net new capital in Q2 2022, opening 1 new position and adding to 15 existing holdings. Its largest new stake was Qualcomm: 11,430 shares worth $1.46M.

By sector, the portfolio is most concentrated in Technology at 52% of assets, up from 48% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was HEICO Corp, an estimated $1.04M trimmed.

  • Brooktree Capital Management's largest Q2 2022 buy was Qualcomm: 11,430 shares worth $1.46M.
  • Brooktree Capital Management added most to Digital Turbine in Q2 2022, an estimated $6.02M increase.
  • Brooktree Capital Management's biggest Q2 2022 reduction was HEICO Corp, cutting an estimated $1.04M.
  • Brooktree Capital Management fully exited Covetrus, Inc. Common Stock in Q2 2022, selling an estimated $3.2M.
  • Brooktree Capital Management's ten largest holdings make up 66% of its $133M portfolio in Q2 2022.
  • Brooktree Capital Management opened 1 new position and closed 5 in Q2 2022.
  • Brooktree Capital Management's portfolio value fell 13% quarter-over-quarter to $133M.

Based on Brooktree Capital Management's 13F filing for Q2 2022, filed 8 Aug 2022.